Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) EBITDA (2016 - 2025)

Historic EBITDA for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to -$40.2 million.

  • Prothena Corp Public's EBITDA rose 3950.05% to -$40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$255.3 million, marking a year-over-year decrease of 5182.28%. This contributed to the annual value of -$154.6 million for FY2024, which is 1909.33% up from last year.
  • Prothena Corp Public's EBITDA amounted to -$40.2 million in Q3 2025, which was up 3950.05% from -$84.6 million recorded in Q2 2025.
  • In the past 5 years, Prothena Corp Public's EBITDA registered a high of $109.2 million during Q3 2021, and its lowest value of -$84.6 million during Q2 2025.
  • In the last 5 years, Prothena Corp Public's EBITDA had a median value of -$43.2 million in 2022 and averaged -$31.3 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 45410.43% in 2021, then plummeted by 10894861.11% in 2023.
  • Prothena Corp Public's EBITDA (Quarter) stood at -$33.1 million in 2021, then soared by 99.78% to -$72000.0 in 2022, then crashed by 108948.61% to -$78.5 million in 2023, then rose by 17.34% to -$64.9 million in 2024, then surged by 37.99% to -$40.2 million in 2025.
  • Its last three reported values are -$40.2 million in Q3 2025, -$84.6 million for Q2 2025, and -$65.6 million during Q1 2025.